These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22169201)

  • 1. Loss of dopaminoreceptive neuron causes L-dopa resistant parkinsonism in tauopathy.
    Chiba S; Takada E; Tadokoro M; Taniguchi T; Kadoyama K; Takenokuchi M; Kato S; Suzuki N
    Neurobiol Aging; 2012 Oct; 33(10):2491-505. PubMed ID: 22169201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SJLB mice develop tauopathy-induced parkinsonism.
    Takenokuchi M; Kadoyama K; Chiba S; Sumida M; Matsuyama S; Saigo K; Taniguchi T
    Neurosci Lett; 2010 Apr; 473(3):182-5. PubMed ID: 20178834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation.
    Rodríguez-Navarro JA; Rodríguez L; Casarejos MJ; Solano RM; Gómez A; Perucho J; Cuervo AM; García de Yébenes J; Mena MA
    Neurobiol Dis; 2010 Sep; 39(3):423-38. PubMed ID: 20546895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
    Lees AJ
    Mov Disord; 2003 Sep; 18 Suppl 6():S28-33. PubMed ID: 14502653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodegenerative disorder FTDP-17-related tau intron 10 +16C → T mutation increases tau exon 10 splicing and causes tauopathy in transgenic mice.
    Umeda T; Yamashita T; Kimura T; Ohnishi K; Takuma H; Ozeki T; Takashima A; Tomiyama T; Mori H
    Am J Pathol; 2013 Jul; 183(1):211-25. PubMed ID: 23680655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
    Dawson HN; Cantillana V; Chen L; Vitek MP
    J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
    Köhler C; Bista P; Götz J; Schröder H
    Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.
    Taniguchi T; Doe N; Matsuyama S; Kitamura Y; Mori H; Saito N; Tanaka C
    FEBS Lett; 2005 Oct; 579(25):5704-12. PubMed ID: 16219306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A 54-year-old man with familial parkinsonism, gaze palsy, and dementia].
    Shimura H; Mori H; Komatsuzaki Y; Nakamura K; Takanashi M; Hattori N; Mizuno Y
    No To Shinkei; 2005 Dec; 57(12):1104-12. PubMed ID: 16375198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic four-repeat tauopathy with frontotemporal degeneration, parkinsonism and motor neuron disease.
    Piao YS; Tan CF; Iwanaga K; Kakita A; Takano H; Nishizawa M; Lashley T; Revesz T; Lees A; de Silva R; Tsujihata M; Takahashi H
    Acta Neuropathol; 2005 Dec; 110(6):600-9. PubMed ID: 16328530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Animal models of tauopathies].
    Higuchi M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys.
    Huot P; Lévesque M; Morissette M; Calon F; Dridi M; Di Paolo T; Parent A
    J Chem Neuroanat; 2008 Jan; 35(1):77-84. PubMed ID: 17706922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment.
    Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S
    Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation.
    Boeve BF; Tremont-Lukats IW; Waclawik AJ; Murrell JR; Hermann B; Jack CR; Shiung MM; Smith GE; Nair AR; Lindor N; Koppikar V; Ghetti B
    Brain; 2005 Apr; 128(Pt 4):752-72. PubMed ID: 15615814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
    Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L; Frohna PA; Joyce JN; Schneider JS
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical, genetic and pathological aspects of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Tsuboi Y
    Rinsho Shinkeigaku; 2004 Nov; 44(11):875-8. PubMed ID: 15651319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
    Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J
    Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A30P α-synuclein impairs dopaminergic fiber regeneration and interacts with L-DOPA replacement in MPTP-treated mice.
    Szego ÉM; Gerhardt E; Kermer P; Schulz JB
    Neurobiol Dis; 2012 Jan; 45(1):591-600. PubMed ID: 22001606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.